Anatumomab mafenatox
Modify Date: 2024-04-03 15:09:50
Anatumomab mafenatox structure
|
Common Name | Anatumomab mafenatox | ||
|---|---|---|---|---|
| CAS Number | 1370261-50-9 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Anatumomab mafenatoxAnatumomab mafenatox (ABR-214936) is a 73 KDa recombinant protein to recognize the tumor-associated antigen 5T4, which is widely expressing in malignancy. Anatumomab mafenatox is between a modified form of SEA and a murine Fab. The main side effects of Anatumomab mafenatox are reported to include fever, low blood pressure, pain, nausea and drowsiness[1]. |
| Name | Anatumomab mafenatox |
|---|
| Description | Anatumomab mafenatox (ABR-214936) is a 73 KDa recombinant protein to recognize the tumor-associated antigen 5T4, which is widely expressing in malignancy. Anatumomab mafenatox is between a modified form of SEA and a murine Fab. The main side effects of Anatumomab mafenatox are reported to include fever, low blood pressure, pain, nausea and drowsiness[1]. |
|---|---|
| Related Catalog | |
| Target |
5T4[1] |
| References |
| No Any Chemical & Physical Properties |